Terms: = Pancreatic cancer AND MITF, WS2A, ENSG00000187098, 4286 AND Diagnosis
5 results:
1. FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.
Hu C; Ye M; Bai J; Liu P; Lu F; Chen J; Xu Y; Yan L; Yu P; Xiao Z; Gu D; Xu L; Tian Y; Tang Q
Cell Mol Life Sci; 2024 Jan; 81(1):50. PubMed ID: 38252148
[TBL] [Abstract] [Full Text] [Related]
2. Clinical histopathological features and CDKN2A/CDK4/mitf mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic.
Dika E; Patrizi A; Rossi C; Turchetti D; Miccoli S; Ferracin M; Veronesi G; Scarfì F; Lambertini M
Ital J Dermatol Venerol; 2021 Oct; 156(5):599-605. PubMed ID: 32221274
[TBL] [Abstract] [Full Text] [Related]
3. Clear cell sarcoma of the pancreas: a case report and review of literature.
Huang J; Luo RK; Du M; Zeng HY; Chen LL; Ji Y
Int J Clin Exp Pathol; 2015; 8(2):2171-5. PubMed ID: 25973121
[TBL] [Abstract] [Full Text] [Related]
4. Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer.
Ren C; Chen Y; Han C; Fu D; Chen H
Tumour Biol; 2014 Nov; 35(11):11467-72. PubMed ID: 25123265
[TBL] [Abstract] [Full Text] [Related]
5. Circulating tumor cells in melanoma patients.
Clawson GA; Kimchi E; Patrick SD; Xin P; Harouaka R; Zheng S; Berg A; Schell T; Staveley-O'Carroll KF; Neves RI; Mosca PJ; Thiboutot D
PLoS One; 2012; 7(7):e41052. PubMed ID: 22829910
[TBL] [Abstract] [Full Text] [Related]